Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 16, 2014
Hovione announced today that the United States Patent and Trademark Office (USPTO) has granted a patent for a capsule-based, low-cost dry powder inhaler (DPI) to Hovione. This happened less than three years after the patent was filed and after just ...
read more
Wednesday, April 16, 2014
Patheon , the pharmaceutical services business owned by DPx Holdings, recently received FDA approval for its Bourgoin, France site to begin manufacturing and selling drugs to the U.S. market. The Bourgoin site specializes in development and ...
read more
Wednesday, April 16, 2014
Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of the CRO services division of Galapagos NV (Euronext: GLPG), which includes both Argenta and BioFocus. The ...
read more
Wednesday, April 02, 2014
Vetter has announced significant progress in its solution for state-of-the-art product packaging, designed to support the prevention of product counterfeiting. This innovative development is in response to expanded requirements by official regulatory...
read more
Wednesday, April 02, 2014
OsoBio has appointed Catherine R. Buck director of manufacturing. In her capacity, Buck is responsible for ensuring that OsoBio’s operations comply with current Good Manufacturing Practices (cGMP) as they apply to the manufacturing of injectable ...
read more
Wednesday, April 02, 2014
INC Research, LLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process® for delivering reliable results, today announced it will feature three senior leaders, including CEO Jamie Macdonald, at this year’s ...
read more
Wednesday, April 02, 2014
ICON plc, (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire Aptiv Solutions ...
read more
Three top executives from Theorem Clinical Research
will be on the agenda at the 23rd Annual Partnerships in Clinical Trials in Las Vegas, March 31-
April 2.
read more
WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D services company with operations in China and the United States, and Pacific Biomarkers (PBI), a premier biomarker laboratory services provider ...
read more
Novozymes Biopharma, part of Novozymes A/S, a world leader in bioinnovation, has today announced a collaboration with Janssen Research & Development, LLC (Janssen). The agreement will enable Janssen to evaluate Novozymes Biopharma’s engineered ...
read more
MRIGlobal and the University of Maryland School of Medicine today announced an intention to collaborate in the development of clinical specimen repositories, laboratory services for clinical trials, and research opportunities. The work will be ...
read more
JLL Partners (JLL), the middle-market private equity firm, and Royal DSM (Euronext: DSM KON), the global Life Sciences and Materials Sciences company, today announced the successful closing of the transaction announced in November 2013 combining DSM ...
read more
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in ...
read more
Alvotech, a powerful new player in the field of biopharmaceuticals and Finesse Solutions, Inc. („Finesse“), today announce that they have entered into a partnership that will provide Alvotech with world-class, scalable, flexible and cost-efficient ...
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced that its High Capacity Manufacturing Facility has been successfully validated for commercial production. $45m (USD) has been invested at...
read more